NO20001897L - Anvendelse av tiazolidindioner for behandling av hyperglycaemi - Google Patents

Anvendelse av tiazolidindioner for behandling av hyperglycaemi

Info

Publication number
NO20001897L
NO20001897L NO20001897A NO20001897A NO20001897L NO 20001897 L NO20001897 L NO 20001897L NO 20001897 A NO20001897 A NO 20001897A NO 20001897 A NO20001897 A NO 20001897A NO 20001897 L NO20001897 L NO 20001897L
Authority
NO
Norway
Prior art keywords
hyperglycaemia
thiazolidinediones
treatment
Prior art date
Application number
NO20001897A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001897D0 (no
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20001897D0 publication Critical patent/NO20001897D0/no
Publication of NO20001897L publication Critical patent/NO20001897L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20001897A 1997-10-13 2000-04-12 Anvendelse av tiazolidindioner for behandling av hyperglycaemi NO20001897L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721692.3A GB9721692D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003067 WO1999018944A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (2)

Publication Number Publication Date
NO20001897D0 NO20001897D0 (no) 2000-04-12
NO20001897L true NO20001897L (no) 2000-06-09

Family

ID=10820481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001897A NO20001897L (no) 1997-10-13 2000-04-12 Anvendelse av tiazolidindioner for behandling av hyperglycaemi

Country Status (24)

Country Link
EP (1) EP1023057A1 (tr)
JP (1) JP2001519383A (tr)
KR (1) KR20010024482A (tr)
CN (1) CN1281358A (tr)
AP (1) AP1223A (tr)
AU (1) AU9547198A (tr)
BG (1) BG104405A (tr)
BR (1) BR9815220A (tr)
CA (1) CA2305289A1 (tr)
CZ (1) CZ20001298A3 (tr)
EA (1) EA200000418A1 (tr)
GB (1) GB9721692D0 (tr)
HR (1) HRP20000256A2 (tr)
HU (1) HUP0003673A3 (tr)
ID (1) ID24439A (tr)
IL (1) IL135515A0 (tr)
NO (1) NO20001897L (tr)
OA (1) OA11519A (tr)
PL (1) PL339804A1 (tr)
SK (1) SK5322000A3 (tr)
TR (1) TR200000957T2 (tr)
UA (1) UA66809C2 (tr)
WO (1) WO1999018944A1 (tr)
YU (1) YU28700A (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140664A0 (en) * 1998-07-21 2002-02-10 Smithkline Beecham Plc Use of glucose uptake enhancer for reducing apoptosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
SK5322000A3 (en) 2000-09-12
CZ20001298A3 (cs) 2001-08-15
GB9721692D0 (en) 1997-12-10
UA66809C2 (uk) 2004-06-15
IL135515A0 (en) 2001-05-20
WO1999018944A1 (en) 1999-04-22
OA11519A (en) 2004-02-09
ID24439A (id) 2000-07-20
HUP0003673A3 (en) 2001-12-28
TR200000957T2 (tr) 2000-08-21
CN1281358A (zh) 2001-01-24
CA2305289A1 (en) 1999-04-22
AP2000001788A0 (en) 2000-06-30
YU28700A (sh) 2003-10-31
BG104405A (en) 2000-12-29
KR20010024482A (ko) 2001-03-26
EP1023057A1 (en) 2000-08-02
PL339804A1 (en) 2001-01-02
HRP20000256A2 (en) 2000-12-31
HUP0003673A2 (hu) 2001-10-28
NO20001897D0 (no) 2000-04-12
AP1223A (en) 2003-11-13
JP2001519383A (ja) 2001-10-23
EA200000418A1 (ru) 2000-10-30
BR9815220A (pt) 2000-11-14
AU9547198A (en) 1999-05-03

Similar Documents

Publication Publication Date Title
NO983266D0 (no) Distribuert Behandling
DE69507757D1 (de) Unterteilte Substratbehandlungskammer
DE69513916T2 (de) Oberflächenbehandlungszusammensetzung
DK0752870T3 (da) Anvendelse af Mycobacterium til behandling af tumorer
DE69807225D1 (de) Vliesstoffbehandlung
DE69613668D1 (de) Wegwerfwindel
NO20003229L (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer
DE59707096D1 (de) Haarbehandlungsmittel zur Festigung der Haare
FI962499A (fi) Herbisidien tehon parantaminen
DE69622461D1 (de) Oberflächenbehandlungszusammensetzung
NO983263D0 (no) Distribuert behandling
IS4789A (is) Meðferðarefnasambönd
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
NO982562D0 (no) Sammensetning for behandling av smerte
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
ATE191034T1 (de) Flüssigkeitsdurchlässiger belag
NO20001897D0 (no) Anvendelse av tiazolidindioner for behandling av hyperglycaemi
NO20001898D0 (no) Anvendelse av tiazolidindioner for behandling av hyperglycaemi
FI101687B1 (fi) Laite pintojen työstämistä varten
NO20000274D0 (no) Behandling av fluider
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
NO996166L (no) FremgangsmÕte for behandling av avluter
UA25791A (uk) Спосіб коhтролю ефективhості лікуваhhя стабільhої стеhокардії
KR970000231U (ko) 표면처리용 브러쉬

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application